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Identity 
Inheritance: autosomal recessive; frequency is about 
2/105 newborns in Ashkenazi Jews and in the Japanese 
(founder effect: affected persons descent from a 
common ancestor); much rarer otherwise. 
Clinics 
Note: 168 cases have been registered in the Bloom's 
syndrome Registry by James German; BS patients are 
predisposed to all types of cancer observed in the 
general population; thus, BS is a model of initiation and 
promotion of cancer, and highligths internal 
causes/processes of cancers. 
Phenotype and clinics 
- Phenotypic spectrum variable. 
- Growth: dwarfism: intrauterine growth retardation; 
birth weight: below 2.3 kg; mean length: 44 cm; adult 
length < 145 cm; 
- Skin: hyperpigmented (café au lait) spots; 
hypopigmented areas; sun sensitive telangiectatic 
erythema; in butterfly configuration across the face: 
resembles lupus erythematosus; 
- Head: microcephaly; dolichocephaly; narrow face; 
prominent nose and/or ears; characteristic high-pitched 
voice; 
- Normal intelligence; 
- Immune deficiency → frequent infections (may be 
life-threatening); 
- Other: myocardopathy; hypogonadism in male 
patients; hypertriglyceridemia. 
Neoplastic risk 
Nearly half of patients have had at least one cancer 
(10% of whom having had more than one primary 
cancer, which is quite characteristic of Bloom's); mean 
age at first cancer onset: 25 yrs (range: 2-49 yrs).  
- Acute leukaemias (ALL and ANLL) in 15 % of cases; 
lymphomas in 15 % as well; these occur mainly before 
the thirties.  
- Carcinomas (of a wide variety) occur in 30 % of 
cases, mainly after the age of 20 yrs.  
- Benign tumours (10%). 
Evolution 
Major medical complications apart from cancers are: 
chronic lung disease, and diabetes mellitus (in 10 %). 
Prognosis 
1/3 of patients are dead at mean age 24 yrs (oldest di d 
at 49 yrs, youngest died before 1 yr) and the mean age 




- Chromatid/chromosome breaks; triradial and 
quadriradial figures, in particular symetrical 
quadriradial configuration involving homologous 
chromosomes (Class I qr), which are pathognomonic 
and which may be due to a mitotic crossing-over; found 
in 3-4% of metaphases (normal: 1/105). 
- Diagnosis is on the (pathognomonic) highly elevatd 
spontaneous sister chromatid exchange rate (90 SCE 
per cell; more than 10 times what is normally found, 
which is about 8-10 SCE per cell with BrDU; 
spontaneous SCE rate (without DNA damaging agent) 
in the normal population being about 1 per cell); in 
some persons a minor population of low SCE cells 
exists, suggesting a recombination event between 
maternal and paternal alleles (with different mutations), 
giving rise to a wild type functional gene (called 
somatic reversion); this allowed to localize the gene in 
a very elegant strategy. 
- Heterozygotes are not detectable by cytogenetic 
studies. 
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Other findings 
Note: slowing of the cell cycle (lenthening of the G1 
and S phases); DNA ligase I deficiency (delayed 
junction of Okazaki fragments). 




Description: ATP binding, DEAH box, and two 
putative nuclear localization signals. 
Localisation: nuclear. 
Function: DNA helicase; probable role in DNA 
replication and repair. 
Homology with the RecQ helicases. 
Mutations 
Germinal: the mutated BLM protein is retained in the 
cytoplasm or both in the cytoplasm and the nucleus, 
while the normal protein is nuclear. 
Somatic: random somatic mutations in random DNA 
segments appear to randomly cause tumour initiation 
and/or progression: every cancer type is over-
represented in this syndrome, and at a much earlier g  
than normal. 
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